Last year marked an increase in federal securities class action filings, with plaintiffs filing 212 cases in 2023, up from 197 in 2022 and ending an overall decline in filings since 2019. Life sciences companies remained...more
Event-driven litigation continues to fuel the rise of securities class actions against public companies, and that has certainly been the case with COVID-19 related litigation. Pandemic-related events have formed the basis for...more
12/2/2020
/ Chamber of Commerce ,
Class Action ,
Coronavirus/COVID-19 ,
Cruise Ships ,
Enforcement Actions ,
Misleading Statements ,
Pharmaceutical Industry ,
Popular ,
Publicly-Traded Companies ,
Securities and Exchange Commission (SEC) ,
Securities Litigation
Life sciences companies were popular targets of class action securities lawsuits in 2018.
In the most recent edition of our annual survey, Dechert litigators David H. Kistenbroker, Joni S. Jacobsen and Angela M. Liu examine...more
2/13/2019
/ Anti-Kickback Statute ,
Class Action ,
Clinical Trials ,
FDA Approval ,
Fraud ,
Life Sciences ,
Material Misstatements ,
Mismanagement ,
Misrepresentation ,
Popular ,
Risk Management ,
Risk Mitigation ,
Securities Fraud ,
Securities Litigation ,
Stock Drop Litigation ,
Surveys
2017 was a record year for class action securities litigation, and life sciences companies continued to be popular targets of such lawsuits. During 2017, plaintiffs filed a total of 88 class action securities lawsuits against...more
2/9/2018
/ Bribery ,
Class Action ,
FDA Approval ,
Insider Trading ,
Life Sciences ,
Misrepresentation ,
Motion to Dismiss ,
Pharmaceutical Industry ,
Scienter ,
Securities Fraud ,
Stock Drop Litigation ,
Surveys
As securities markets become increasingly interconnected, multi- national public corporations continue to be a part of a significant sea change in the globalization of securities fraud litigation—a change that began with the...more
11/22/2017
/ Australia ,
Banks ,
Canada ,
Class Action ,
Collective Actions ,
Cross-Border Transactions ,
Extraterritoriality Rules ,
Foreign Issuers ,
Forum Shopping ,
Global Marketplace ,
India ,
International Litigation ,
Italy ,
Japan ,
Jurisdiction ,
Litigation Funding ,
Morrison v National Australia Bank ,
SCOTUS ,
Securities ,
Securities and Exchange Commission (SEC) ,
Securities Exchange Act ,
Securities Litigation ,
Spain ,
Third-Party Relationships
Officers, directors, and underwriters frequently become targets of securities fraud litigation after a public offering. In a landmark case decided yesterday, the U.S. Supreme Court provides defendants with another tool to...more
6/28/2017
/ Board of Directors ,
CalPERS v ANZ Securities ,
Class Action ,
Corporate Officers ,
Equitable Tolling ,
Opt-Outs ,
Pension Funds ,
Public Offerings ,
SCOTUS ,
Section 11 ,
Section 13 ,
Securities Act ,
Securities Act of 1933 ,
Securities Fraud ,
Securities Litigation ,
Statute of Limitations ,
Statute of Repose ,
Underwriting
Life sciences companies continued to be popular targets of securities fraud class action lawsuits filed in 2016, and prudent life sciences companies should take heed of the results of this year’s decisions. In 2016,...more
3/9/2017
/ Antitrust Violations ,
Class Action ,
Drug Pricing ,
False Statements ,
FDA Approval ,
Generic Drugs ,
Life Sciences ,
Material Misrepresentation ,
Omissions ,
Popular ,
Price-Fixing ,
Promotional Items ,
Risk Mitigation ,
Securities Fraud ,
Stock Drop Litigation
A closely-watched set of claims stemming back to the 2008 global financial crisis has settled for a massive €1.204 billion (US$1.3 billion), making it one of the highest settlements ever and ushering in a new era in the...more
3/21/2016
/ Bailout ,
Class Action ,
Corporate Counsel ,
Foreign Investment ,
International Litigation ,
Netherlands ,
Oil & Gas ,
Rule 10(b) ,
Securities Fraud ,
Securities Litigation ,
Settlement ,
Young Lawyers
In Amgen Inc. v. Connecticut Retirement Plans and Trust Funds, No. 11-1085, 568 U.S. ___ (2013), decided on February 27, 2013, the Supreme Court of the United States affirmed the Ninth Circuit’s ruling that, in a case...more